Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2008
05/07/2008CN100386090C Medical dust cloud agent or granular agent and its use
05/07/2008CN100386089C Compound lentinan preparation and its preparing method
05/07/2008CN100386088C Medicine for treating pharyngitis and its preparing method
05/07/2008CN100386087C Use of kutkin I in preparing drug for treating hepatitis B
05/07/2008CN100386086C Dispersed compound tablet of glycyrrhizic acid and glycyrrhizinate and its preparing process
05/07/2008CN100386085C Fat Emulsion transfusion liquid for preventing and curing tumour and production method thereof
05/07/2008CN100386084C Health tooth paste composition
05/07/2008CN100386083C Methods of using vitamind compounds in the treatment of myelodysplastic syndromes
05/07/2008CN100386082C Oryzanol composition and its preparation method
05/07/2008CN100386081C Injection containing tricyclofluoro quinolone sulfonate and its preparing method and use
05/07/2008CN100386080C Tetrandrine solid lipide nano particle and its preparing method
05/07/2008CN100386079C Injection use-powder ampoule for inhibiting thrombocyte agglutination and its preparation method
05/07/2008CN100386078C Nimodipine emulsion injection liquid and method for preparing the same
05/07/2008CN100386077C Coated norcantharidin tablet and its preparing method
05/07/2008CN100386076C Cardiovascular pharmaceutical formulation preparation method and uses
05/07/2008CN100386075C Medicine capable of promoting height elevation and formulation thereof
05/07/2008CN100386074C Retinoic acid and the like oral formulation
05/07/2008CN100386073C Transdermal drug administering system
05/07/2008CN100386071C Medicine for treating cough and chronic bronchitis
05/07/2008CN100386070C Pharmaceutical formulation comprising melatonin
05/07/2008CN100386069C Brilliant mycomycin elaioplast preparation and its making method
05/07/2008CN100386068C Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
05/07/2008CN100386024C Synergistic microbicidal combination
05/06/2008USRE40300 Carbon dioxide enhancement of inhalation therapy
05/06/2008US7368609 e.g., N-(1-[3,5-bis(trifluoromethyl)phenyl]ethyl)-N-methyl-N-(1-phenylethyl)amine; intermediates for medicines and agricultural chemicals
05/06/2008US7368583 Process for recovery of plant sterols from by-product of vegetable oil refining
05/06/2008US7368577 Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
05/06/2008US7368576 Treating breast cancer by dministering a fibroblast activation protein alpha inhibitor is a thiazolidine or a pyrrolidine linked to an amino acid by a peptide bond, e.g., L-threo-isoleucyl pyrrolidine, L-allo-isoleucyl thiazolidine, L-allo-isoleucyl pyrrolydine, L-glutaminyl thiazolidine
05/06/2008US7368575 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries
05/06/2008US7368574 crystalline hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl) amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, used as hypoglycemic, antilipemic or antidiabetic agents
05/06/2008US7368573 Triamide-substituted heterobicyclic compounds
05/06/2008US7368572 Anticancer agents
05/06/2008US7368571 HIV-Integrase inhibitors, pharmaceutical compositions and methods for their use
05/06/2008US7368570 organometallic singlet oxygen photosensitizer, comprising a metal and one or more ligands, wherein at least one of said ligands has a carbon atom that is covalently bonded to the metal.
05/06/2008US7368565 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
05/06/2008US7368563 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, alzheimer's, demyelination and lowering plasma levels of sterols
05/06/2008US7368562 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, demyelination and lowering plasma levels of sterols
05/06/2008US7368545 PCA3 messenger RNA species in benign and malignant prostate tissues
05/06/2008US7368530 Human intestinal Npt2B
05/06/2008US7368502 Hydroxyphenyl cross-linked macromolecular network and applications thereof
05/06/2008US7368480 Reducing side effects while elevating serum testosterone levels; having higher trans to cis ratio
05/06/2008US7368479 Alpha-sulfonylamino-acetonitriles
05/06/2008US7368478 Methods for inhibiting angiogenesis and tumor growth
05/06/2008US7368477 Benzofuranyl alkanamine derivatives and uses thereof
05/06/2008US7368476 4-{2-[3-benzofuran-2-yl-4-(2-pyrrolidin-1-ylethoxy)but-2-enoylamino]-ethoxy}-N-hydroxybenzamide hydrochloride; anticancer, bipolar disorders; inhibitors of histone deacetylase
05/06/2008US7368475 high and selective activity against Cytomegalovirus
05/06/2008US7368473 Paclitaxel enhancer compounds
05/06/2008US7368472 1,2,4-Triaminobenzene derivatives useful for treating disorders of the central nervous system
05/06/2008US7368471 fibrinolytic disorders such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis, Alzheimer's disease; {1-Methyl-6-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid
05/06/2008US7368470 Such as (4-propyl-phenyl)-{3-[1-(4-trifluoromethyl-benzyl)-1H-indol-3-yl]-pyrrolidin-1-yl}-methanone; treatment of pain and/or depression
05/06/2008US7368469 Prophylaxis of stroke, cardiovascular death or myocardial infarction by administering an angiotenzin converting enzyme inhibitor: ramipril, ramiprilat or their salts, optionally together with another antihypertensive, a cholesterol lowering agent, a diuretic or aspirin
05/06/2008US7368468 hypercholesterolemia or hyperlipidemia; crystallization; using acetonitrile and NaOH
05/06/2008US7368467 Calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders
05/06/2008US7368465 Metalloproteinase inhibitors
05/06/2008US7368464 Alkylating 4-amino-1,2,4-triazole with a stearically hindered methyl oxirane; chemical intermediates, fungicidal compositions for cereal diseases
05/06/2008US7368463 Substituted 4-amino-1-benzylpiperidine compounds
05/06/2008US7368462 4'-Fluoro-biphenyl-4-carboxylic acid (6-dimethylaminomethyl-naphthalen-1-ylmethyl)-amide; obesity; side effects reduction; selective binding; no stimulation of the central nervous system and no peripheral activity caused by activation of 5-HT2c receptors; improved cellular potency and pharmacokinetics
05/06/2008US7368461 Compounds and method for the treatment of overactive bladder
05/06/2008US7368460 Tropane derivatives useful in therapy
05/06/2008US7368459 Heterocyclic compounds
05/06/2008US7368458 N-(1-Benzyl-2-oxo-6-phenyl-1,2,3,4-tetrahydro-1,8-naphthyridin-3-yl)benzenesulfonamide; antagonists; regulation of appetite; obesity; smoking cessation
05/06/2008US7368457 Bridged N-arylsulfonylpiperidines as gamma-secretase inhibitors
05/06/2008US7368456 Methods, compositions, and kits for organ protection during systemic anticancer therapy
05/06/2008US7368455 2-(4-fluorophenyl)-3-[2-(2-methoxy-1-methylethylamino)pyrimidin-4-yl]-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-one; cytokines (interleukin-1, 6, 8 and Tumor Necrosis Factor- alpha) inhibitor; antiinflammatory and antiarthritic agents; osteoporosis, rheumatic diseases; antidiabetic
05/06/2008US7368454 serotonin receptor modulator; antidepressant, anxiolytic agent; drug abuse; schizophrenia
05/06/2008US7368453 Quinazolinone compounds with reduced bioaccumulation
05/06/2008US7368451 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects
05/06/2008US7368450 Sodium channel blockers
05/06/2008US7368449 2-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
05/06/2008US7368448 2-(arylalkoxy)-1-phenylethylamine derivatives as NK1 antagonist and serotonin reuptake inhibitors
05/06/2008US7368447 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects
05/06/2008US7368446 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
05/06/2008US7368445 Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms
05/06/2008US7368444 4-Hydroxy-1-toluenesulfonyl-2,3,4,5-tetrahydro-1H-1-benzazepine, for example; useful as the preventive and/or treatment medicine against diseases caused by stress
05/06/2008US7368443 Central nervous system disorders, drug abuse, obesity
05/06/2008US7368442 Nitrate esters of corticoid compounds and pharmaceutical applications thereof
05/06/2008US7368441 Using 2-(carbamimidoyl -methyl-amino) ethoxy phosphoric acid in fine particle size
05/06/2008US7368440 Methods for the administration of amifostine and related compounds
05/06/2008US7368439 Prevention or treatment of disorders modulated by P2Y receptors such as type 2 diabetes, cystic fibrosis and cancer
05/06/2008US7368438 Non-nucleotide compositions and method for inhibiting platelet aggregation
05/06/2008US7368437 Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents
05/06/2008US7368436 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state
05/06/2008US7368435 Topical endoparasiticide and ectoparasiticide formulations
05/06/2008US7368434 Alcoholism therapy
05/06/2008US7368431 Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon
05/06/2008US7368430 A cell-permeable nuclear factor-kappa B (NF-KB) inhibitor comprising a peptide fragment of the p65 subunit of NF- KB comprising phosphorylation site(s) and an antennapedia-derived protein transduction domain; inhibit inflammatory stimuli; gene expression inhibitors; apoptosis; anticarcinogenic agents
05/06/2008US7368428 Contacting tumor cells to glycoprtorein 88 (GP88) antagonists (e.g., anti-GP88 antibodies, anti-GP88 antisense nucleic acids, GP88 siRNA, and small molecules); antiestrogen and cytotoxic therapy
05/06/2008US7368423 Composition and method for treating chronic allograft rejection
05/06/2008US7368422 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
05/06/2008US7368287 For treatment and/or prevention of inflammation and autoimmune disease; vaccines
05/06/2008US7368254 Lipid-based systems for targeting diagnostic agents
05/06/2008US7368250 Using monoclonal antibody specific to tumor cell as diagnostic and therapeutic tool in detection and treatment of cancer; immunodiagnostics; immunotherapy
05/06/2008US7368244 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics
05/06/2008US7368236 Methods of producing nucleic acid ligands
05/06/2008US7368169 Hydrazide compounds with angiogenic activity
05/06/2008US7368144 Removal of shell, pulp; grinding in presence of solvent; macerating, extraction. filtration
05/06/2008US7368138 Preferential extraction of sterols and fatty acids using mixtures of ethanol and water; efficiency
05/06/2008US7368137 Smilagenin and its use
05/06/2008US7368131 Method and composition for treating hypopigmentation of the hair and skin
05/06/2008US7368122 Non-irritating emulsion that may be used for treating, protecting or preventing dermatitic skin, especially eczema, or as a vehicle to deliver a pharmacological agent or drug topically to treat or prevent dermatitis